ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 30367205

The current role and future directions of circulating tumor cells and circulating tumor DNA in urothelial carcinoma of the bladder.

Rink M and 3 others. World J Urol, 2019. Cited by 18 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The current role and future directions of circulating tumor cells and circulating tumor DNA in urothelial carcinoma of the bladder. Papers, record 30367205. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30367205

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The current role and future directions of circulating tumor cells and circulating tumor DNA in urothelial carcinoma of the bladder.
PubMed
Journal
World J Urol
PubMed
Year
2019
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
0.69
iCite
Revised in PubMed
2026-10-12
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rink MMichael
2Schwarzenbach HHeidi
3Riethdorf SSabine
4Soave AArmin

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Transitional CellMajor topic
Circulating Tumor DNAMajor topic
DNA, NeoplasmMajor topic
Neoplastic Cells, CirculatingMajor topic
Urinary Bladder NeoplasmsMajor topic
Forecasting
Humans

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References82

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129,355,669Clinical applications of the CellSearch platform in cancer patients.Adv Drug Deliv Rev2018https://conductscience.org/library/papers/29355669PubMed
226,410,730Second Line Chemotherapy for Advanced and Metastatic Urothelial Carcinoma: Vinflunine and Beyond-A Comprehensive Review of the Current Literature.J Urol2016https://conductscience.org/library/papers/26410730PubMed
328,645,491Systematic Review of Immune Checkpoint Inhibition in Urological Cancers.Eur Urol2017https://conductscience.org/library/papers/28645491PubMed
418,006,010Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer.J Urol2008https://conductscience.org/library/papers/18006010PubMed
529,432,873Characterization of Urothelial Cancer Circulating Tumor Cells with a Novel Selection-Free Method.Urology2018https://conductscience.org/library/papers/29432873PubMed
615,317,891Circulating tumor cells, disease progression, and survival in metastatic breast cancer.N Engl J Med2004https://conductscience.org/library/papers/15317891PubMed
718,829,513Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.Clin Cancer Res2008https://conductscience.org/library/papers/18829513PubMed
820,870,429Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies.Urol Oncol2012https://conductscience.org/library/papers/20870429PubMed
923,770,567Mutational heterogeneity in cancer and the search for new cancer-associated genes.Nature2013https://conductscience.org/library/papers/23770567PubMed
1028,760,909Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer.Clin Cancer Res2017https://conductscience.org/library/papers/28760909PubMed

1 to 10 of 82

See all 82 references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
41,614,220Emerging Role of ctDNA Fragmentomics and Epigenetic Signatures in the Early Detection, Minimal Residual Disease Assessment, and Precision Monitoring of Renal Cell Carcinoma.J Cell Mol Med2026https://conductscience.org/library/papers/41614220PubMed
38,956,768Advances in Liquid Biopsy for Diagnosis of Bladder Cancer.Int Neurourol J2024https://conductscience.org/library/papers/38956768PubMed
37,183,202Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder.World J Urol2023https://conductscience.org/library/papers/37183202PubMed
36,980,339Circulating Tumor Cells Predict Response of Neoadjuvant Chemotherapy in Patients with Bladder Cancer: A Preliminary Study.Diagnostics (Basel)2023https://conductscience.org/library/papers/36980339PubMed
33,559,760Management of Clinically Regional Node-Positive Urothelial Carcinoma of the Bladder.Curr Oncol Rep2021https://conductscience.org/library/papers/33559760PubMed
33,298,978Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy.Sci Rep2020https://conductscience.org/library/papers/33298978PubMed
33,209,903ctDNA facilitated the diagnosis of a patient with synchronous urothelial carcinoma and non-small cell lung cancer: case report.Ann Transl Med2020https://conductscience.org/library/papers/33209903PubMed
33,126,664The Impact of Circulating Tumor Cells on Venous Thromboembolism and Cardiovascular Events in Bladder Cancer Patients Treated with Radical Cystectomy.J Clin Med2020https://conductscience.org/library/papers/33126664PubMed
32,620,920Circulating proteomic signature for detection of biomarkers in bladder cancer patients.Sci Rep2020https://conductscience.org/library/papers/32620920PubMed
31,352,566Hope, hype and biology: the current biomarker landscape in bladder cancer.World J Urol2019https://conductscience.org/library/papers/31352566PubMed

1 to 10 of 11

See all 11 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30367205

GET https://conductscience.org/api/papers/v1/30367205/references?page=2

API referenceFor AI assistants